Psychiatry and Neurology, Neurology · Long Beach, CA
NPI
1356630370
Since 2011
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
701 E 28th St Ste 319
Long Beach, CA, 90806
Phone (562) 426-3656
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
646 services
Medicare patients, 2024
235
Average age 73
Drug cost, 2024
$1.7M
3,909 prescriptions
Company payments, 2025
$5,293
From 31 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Parissa Vassef was code 99214 (office e&m - established), 327 times for 170 patients. In total Parissa Vassef billed 646 services in 13 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-11-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 327 | 170 | $100.08 | $33K |
| 99215 Office E&M - Established | Office | 81 | 46 | $148.27 | $12K |
| 96116 Behavioral Health Services | Office | 64 | 35 | $74.92 | $4,795 |
| 99204 Office E&M - New | Office | 43 | 43 | $128.43 | $5,522 |
| 99205 Office E&M - New | Office | 40 | 40 | $178.22 | $7,129 |
| 99213 Office E&M - Established | Office | 31 | 28 | $61.85 | $1,917 |
| 95816 Neurologic | Office | 24 | 24 | $353.83 | $8,492 |
Medicare prescription drug claims, 2024
In 2024, the drug Parissa Vassef prescribed most often to Medicare patients was Memantine Hcl, with 383 prescriptions and refills. In total Parissa Vassef wrote 3,909 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 383 | 666 | 103 | $9,399 |
| Donepezil Hcl Generic | 261 | 571 | 80 | $2,362 |
| Memantine Hcl Er Memantine Hcl | 224 | 347 | 49 | $29K |
| Gabapentin Generic | 201 | 366 | 77 | $3,252 |
| Donepezil Hcl Odt Donepezil Hcl | 191 | 314 | 59 | $4,291 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 186 | 349 | 48 | $3,582 |
| Levetiracetam Generic | 120 | 295 | 30 | $4,769 |
| Topiramate Generic | 100 | 170 | 29 | $863 |
| Escitalopram Oxalate Generic | 88 | 176 | 21 | $1,473 |
| Rivastigmine Generic | 74 | 84 | 16 | $12K |
| Lamotrigine Generic | 67 | 164 | 15 | $820 |
| Zonisamide Generic | 67 | 127 | 15 | $1,429 |
| Entacapone Generic | 63 | 103 | 16 | $12K |
| Nortriptyline Hcl Generic | 57 | 86 | 19 | $626 |
| Serevent Diskus Salmeterol Xinafoate | 56 | 67 | 17 | $27K |
Brand drugs: - claims; generic drugs: 3,391 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Parissa Vassef $5,293 ($5,293 in general payments such as food, travel and fees) from 31 companies. The largest payer was Abbvie Inc. with $631.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 33 | $631 |
| Neurocrine BioSciences, Inc. NBIX | 24 | $504 |
| Novartis Pharmaceuticals Corporation NVS | 34 | $497 |
| Biogen, Inc. BIIB | 21 | $433 |
| EMD Serono, Inc. MRK.DE | 15 | $322 |
| Lundbeck LLC | 13 | $307 |
| MDD US Operations, LLC | 14 | $255 |
| Alexion Pharmaceuticals, Inc. AZN | 8 | $248 |
| Amgen Inc. AMGN | 10 | $214 |
| SK Life Science, Inc. | 7 | $181 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.